Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ICP-332
DRUG
2 trials
Sponsors
Beijing InnoCare Pharma Tech Co., Ltd.
Conditions
Healthy Subjects
Moderate to Severe Atopic Dermatitis
Phase 1
A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy Subjects
Completed
NCT05399030
Beijing InnoCare Pharma Tech Co., Ltd.
Healthy Subjects
Start: 2021-08-14
End: 2022-02-18
Updated: 2022-08-08
Phase 2
Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis
NCT05702268
Beijing InnoCare Pharma Tech Co., Ltd.
Moderate to Severe Atopic Dermatitis
Start: 2023-03-18
End: 2023-12-30
Target: 75
Updated: 2023-05-22
Related Papers
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.
2026-01-14